Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy

S. Yokoyama(Suzuka University of Medical Science), Kazuya Ooi(Suzuka University of Medical Science), Akiya Mori, Takuya Iwamoto(Mie University Hospital), Shinya Tamaki, Toshiro Mizuno(Mie University), Keiki Kawakami, Takaaki Ao, Yasuhiko Sakata(Tohoku University), Makoto Simomura(Soka Municipal Hospital), Shinichi Kageyama, Tomokazu Yamakawa(Mie Chuo Medical Center), Satoshi Tamaru, Kenichi Watanabe, Susumu Ban(Hokkaido University), Naomi Konishi(Mie Chuo Medical Center), Daisuke Nakanishi(Soka Municipal Hospital), Shoichiro Ohtani(Hiroshima Prefectural Rehabilitation Center), Tomomi Yamada(Osaka University Hospital)
Clinical Breast Cancer
June 29, 2017
Cited by 5


Related Papers